MedTrace Logo

Urinary Protein/Creatinine Ratio in a Single Urine Sample Versus 24-hour Proteinuria in Patients With Multiple Myeloma

NCT01572857 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2018-09-11

No results posted yet for this study

Summary

The measurement of 24-hour proteinuria allows an assessment of treatment response in patients with multiple myeloma. But it is difficult and restrictive to make.

This study was therefore designed to investigate the correlation between the ratio of proteinuria / creatinine on samples, easier to obtain, and the 24-hour proteinuria in assessing response to this treatment .

Conditions

Interventions

BIOLOGICAL

urinary excretion of FLC immunoglobulin

First phase : Collection of four urine samples daily for 2 days: * Of the 24-hour urine * at 8 AM * at 12 AM * at 4 PM On each of these urine samples, the following analysis will be performed: * Proteinuria * Albuminuria * Urinary FLC (Freelite ™) * Urine creatinine Second phase: Determination of creatinine in 24 hours by measuring the creatinine of 24 hours 3 days in a row.

Sponsors & Collaborators

  • Rennes University Hospital

    lead OTHER

Principal Investigators

  • Olivier DECAUX, MD · Service de Medecine interne - Hôpital Sud - Rennes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-04-30
Primary Completion
2018-01-31
Completion
2018-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01572857 on ClinicalTrials.gov